Illinois released sales figures for several months today. The last time it had released data, it was for adult-use cannabis in May. The document today explained that the switch to Metrc had been the cause of the lack of data. “The sales tracking features in Metrc help retailers more accurately and reliably report actual sales, including all discounts and promotions at checkout. A thorough review of past data indicates prior months collected some pre-discount prices.”

The state’s adult-use cannabis sales were up 7.5% sequentially in October to $113.1 million, an increase on a per-day basis of 4.0%. The year-over-year growth was -20.5%. Here is the chart of the adult-use sales over time:

After increasing 106% in 2021, 13% in 2022 and then 5% in 2023, year-to-date adult-use sales were up 5.4% in 2024 to $1.72 billion.  So far in 2025, they are down 9.9%.

There has been no update on medical cannabis from the state in a while. The state separately releases sales from its medical program, and the release for April showed that sales fell 1.6% sequentially to $19.7 million, which was down 13.2% from a year ago.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email